Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating third-quarter expectations and raising its guidance.

B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for the industry. The stock has also outperformed the sector and the S&P ...

特拉维夫 - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) 周三公布的第三季度业绩好于预期，并上调了全年指引，使其股价在盘前交易中上涨3%。

Shares of Teva Pharmaceutical (NYSE:TEVA) gained in the premarket trading on Wednesday after the generic drugmaker reported better-than-expected Q3 2024 financials and raised its full-year outlook ...

Teva Pharmaceutical Industries Ltd. (TEVA) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance ...

Teva Pharmaceutical Industries (TEVA) is a stock many investors are watching right now. TEVA is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock is trading with P/E ...

How the price action of Teva Pharmaceutical Industries Limited American Depositary Shares TEVA is used to our Advantage ...

Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday.